For: | Di Tommaso L, Spadaccini M, Donadon M, Personeni N, Elamin A, Aghemo A, Lleo A. Role of liver biopsy in hepatocellular carcinoma. World J Gastroenterol 2019; 25(40): 6041-6052 [PMID: 31686761 DOI: 10.3748/wjg.v25.i40.6041] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v25/i40/6041.htm |
Number | Citing Articles |
1 |
Ming Xiong, Yaona Xu, Yang Zhao, Si He, Qihan Zhu, Yi Wu, Xiaofei Hu, Li Liu. Quantitative analysis of artificial intelligence on liver cancer: A bibliometric analysis. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.990306
|
2 |
Pierleone Lucatelli, Marta Burrel, Boris Guiu, Gianluca de Rubeis, Otto van Delden, Thomas Helmberger. CIRSE Standards of Practice on Hepatic Transarterial Chemoembolisation. CardioVascular and Interventional Radiology 2021; 44(12): 1851 doi: 10.1007/s00270-021-02968-1
|
3 |
Justin R. Tse, Kevin Terashima, Luyao Shen, Justin P. McWilliams, David S. K. Lu, Steven S. Raman. Safety of percutaneous, image-guided biopsy of hepatocellular carcinoma with and without concurrent ablation. Abdominal Radiology 2022; 47(8): 2640 doi: 10.1007/s00261-022-03494-5
|
4 |
Yusuke Ozeki, Naoya Kanogawa, Sadahisa Ogasawara, Keita Ogawa, Takamasa Ishino, Miyuki Nakagawa, Kisako Fujiwara, Hidemi Unozawa, Terunao Iwanaga, Takafumi Sakuma, Naoto Fujita, Ryuta Kojima, Hiroaki Kanzaki, Keisuke Koroki, Kazufumi Kobayashi, Masato Nakamura, Soichiro Kiyono, Takayuki Kondo, Tomoko Saito, Ryo Nakagawa, Eiichiro Suzuki, Yoshihiko Ooka, Shingo Nakamoto, Ryosuke Muroyama, Akinobu Tawada, Tetsuhiro Chiba, Makoto Arai, Jun Kato, Jun-ichiro Ikeda, Yuichi Takiguchi, Naoya Kato. Liver biopsy technique in the era of genomic cancer therapies: a single-center retrospective analysis. International Journal of Clinical Oncology 2022; 27(9): 1459 doi: 10.1007/s10147-022-02195-9
|
5 |
Keith Wan Hang Chiu, Kel Vin Tan, Xinxiang Yang, Xiaoqiang Zhu, Jingjing Shi, Chi-Leung Chiang, Lawrence Chan, Yuan Hui, Pek-Lan Khong, Kwan Man, Jason Wing Hon Wong. Prognostic PET [11C]-acetate uptake is associated with hypoxia gene expression in patients with late-stage hepatocellular carcinoma – a bench to bed study. Cancer Imaging 2024; 24(1) doi: 10.1186/s40644-024-00685-9
|
6 |
Yang Yan, Xiao Shi Lin, Wang Zheng Ming, Zhang Qi Chuan, Gan Hui, Sun Ya Juan, Wang Shuang, LV Yang Fan, Zhang Dong. Radiomic Analysis Based on Gd-EOB-DTPA Enhanced MRI for the Preoperative Prediction of Ki-67 Expression in Hepatocellular Carcinoma. Academic Radiology 2024; 31(3): 859 doi: 10.1016/j.acra.2023.07.019
|
7 |
Ryo Shimizu, Yoshiyuki Ida, Masayuki Kitano. Predicting Outcome after Percutaneous Ablation for Early-Stage Hepatocellular Carcinoma Using Various Imaging Modalities. Diagnostics 2023; 13(19): 3058 doi: 10.3390/diagnostics13193058
|
8 |
Alberto Molares-Vila, Alberte Corbalán-Rivas, Miguel Carnero-Gregorio, José Luís González-Cespón, Carmen Rodríguez-Cerdeira. Biomarkers in Glycogen Storage Diseases: An Update. International Journal of Molecular Sciences 2021; 22(9): 4381 doi: 10.3390/ijms22094381
|
9 |
Haiyi Long, Wenxin Xu, Xian Zhong, Zebin Chen, Liya Su, Yu Duan, Yifan Shi, Xiaoyan Xie, Manxia Lin. Feasibility of liver stiffness measured using two-dimensional shear wave elastography in assessing preoperative liver function for patients with hepatocellular carcinoma. Abdominal Radiology 2022; 47(2): 664 doi: 10.1007/s00261-021-03374-4
|
10 |
Gabriela Perdomo CORAL, Fernanda BRANCO, Rosalva MEURER, Patrícia dos Santos MARCON, Paulo Roberto Ott FONTES, Angelo Alves de MATTOS. RESULTS OF IMMUNOHISTOCHEMISTRY IN THE DIFFERENTIAL DIAGNOSIS OF EARLY HEPATOCELLULAR CARCINOMA AND NODULES WITH HIGH-GRADE DYSPLASIA IN PATIENTS WITH CIRRHOSIS. Arquivos de Gastroenterologia 2021; 58(1): 82 doi: 10.1590/s0004-2803.202100000-14
|
11 |
Elena V. Potapova, Valery V. Shupletsov, Viktor V. Dremin, Evgenii A. Zherebtsov, Andrian V. Mamoshin, Andrey V. Dunaev. In Vivo Time‐Resolved Fluorescence Detection of Liver Cancer Supported by Machine Learning. Lasers in Surgery and Medicine 2024; doi: 10.1002/lsm.23861
|
12 |
Germán Osorio-Sandoval, Nancy Johana Mejía-Vargas, Juan Camilo Pérez-Cadavid, Alejandro Cardona-Palacio. Hiperbilirrubinemia: visión del patólogo. Hepatología 2022; : 176 doi: 10.52784/27112330.157
|
13 |
Minetta C. Liu, Matthew MacKay, Matthew Kase, Aneta Piwowarczyk, Christine Lo, Jeff Schaeffer, Justin D. Finkle, Christopher E. Mason, Nike Beaubier, Kimberly L. Blackwell, Ben Ho Park. Longitudinal Shifts of Solid Tumor and Liquid Biopsy Sequencing Concordance in Metastatic Breast Cancer. JCO Precision Oncology 2022; (6) doi: 10.1200/PO.21.00321
|
14 |
Irfan A. Kazi, Vinay Jahagirdar, Bareen W. Kabir, Almaan K. Syed, Asad W. Kabir, Abhilash Perisetti. Role of Imaging in Screening for Hepatocellular Carcinoma. Cancers 2024; 16(19): 3400 doi: 10.3390/cancers16193400
|
15 |
Shaoming Song, Mingzhen Bai, Xiaofei Li, Shiyi Gong, Wenwen Yang, Caining Lei, Hongwei Tian, Moubo Si, Xiangyong Hao, Tiankang Guo. Early predictive value of circulating biomarkers for sorafenib in advanced hepatocellular carcinoma. Expert Review of Molecular Diagnostics 2022; 22(3): 361 doi: 10.1080/14737159.2022.2049248
|
16 |
Nese Karadag Soylu. Update on Hepatocellular Carcinoma: a Brief Review from Pathologist Standpoint. Journal of Gastrointestinal Cancer 2020; 51(4): 1176 doi: 10.1007/s12029-020-00499-5
|
17 |
Shivani R Kale, Geeta Karande, Anand Gudur, Aishwarya Garud, Monika S Patil, Satish Patil. Recent Trends in Liver Cancer: Epidemiology, Risk Factors, and Diagnostic Techniques. Cureus 2024; doi: 10.7759/cureus.72239
|
18 |
Ariel Jaffe, Tamar H. Taddei, Edoardo G. Giannini, Ysabel C. Ilagan‐Ying, Massimo Colombo, Mario Strazzabosco. Holistic management of hepatocellular carcinoma: The hepatologist's comprehensive playbook. Liver International 2022; 42(12): 2607 doi: 10.1111/liv.15432
|
19 |
Marcel Christian Langenbach, Thomas Joseph Vogl, Amelie Buchinger, Katrin Eichler, Jan-Erik Scholtz, Renate Hammerstingl, Tatjana Gruber-Rouh. CT-guided biopsies of unspecified suspect intrahepatic lesions: pre-procedure Lipiodol-marking improves the biopsy success rate. Radiology and Oncology 2023; 57(2): 158 doi: 10.2478/raon-2023-0024
|
20 |
Hugo Pinto-Marques, Joana Cardoso, Sílvia Silva, João L. Neto, Maria Gonçalves-Reis, Daniela Proença, Marta Mesquita, André Manso, Sara Carapeta, Mafalda Sobral, Antonio Figueiredo, Clara Rodrigues, Adelaide Milheiro, Ana Carvalho, Rui Perdigoto, Eduardo Barroso, José B. Pereira-Leal. A Gene Expression Signature to Select Hepatocellular Carcinoma Patients for Liver Transplantation. Annals of Surgery 2022; 276(5): 868 doi: 10.1097/SLA.0000000000005637
|
21 |
Cristina Dopazo, Kjetil Søreide, Elena Rangelova, Sven Mieog, Lucia Carrion-Alvarez, Rafael Diaz-Nieto, Florian Primavesi, Stefan Stättner. Hepatocellular carcinoma. European Journal of Surgical Oncology 2024; 50(1): 107313 doi: 10.1016/j.ejso.2023.107313
|
22 |
Lisui Zhou, Yuan Qu, Guangnan Quan, Houdong Zuo, Mi Liu. Nomogram for Predicting Microvascular Invasion in Hepatocellular Carcinoma Using Gadoxetic Acid-Enhanced MRI and Intravoxel Incoherent Motion Imaging. Academic Radiology 2024; 31(2): 457 doi: 10.1016/j.acra.2023.06.028
|
23 |
Hannah Yang, Beodeul Kang, Yeonjung Ha, Sung Hwan Lee, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Gwangil Kim, Sanghoon Jung, Sun Young Rha, Vincent E. Gaillard, Jaekyung Cheon, Chan Kim, Hong Jae Chon. High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma. JHEP Reports 2023; 5(4): 100672 doi: 10.1016/j.jhepr.2023.100672
|
24 |
Tao Wang, Wanxiang Wang, Jinfu Zhang, Xianwei Yang, Shu Shen, Wentao Wang. Development and Validation of a Nomogram for Differentiating Combined Hepatocellular Cholangiocarcinoma From Intrahepatic Cholangiocarcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.598433
|
25 |
Suresh Subramanian, Madhava B. Mallia, Ajit S. Shinto, Ashwathy S. Mathew. Clinical Management of Liver Cancer in India and Other Developing Nations: A Focus on Radiation Based Strategies. Oncology and Therapy 2021; 9(2): 273 doi: 10.1007/s40487-021-00154-4
|
26 |
Jiejun Chen, Yixian Guo, Yinglong Guo, Mengmeng Jiang, Yunfei Zhang, Yongming Dai, Xiuzhong Yao. Preoperative assessment of microvascular invasion of hepatocellular carcinoma using non-Gaussian diffusion-weighted imaging with a fractional order calculus model: A pilot study. Magnetic Resonance Imaging 2023; 95: 110 doi: 10.1016/j.mri.2021.09.003
|
27 |
Haris Muhammad, Aniqa Tehreem, Peng-Sheng Ting, Merve Gurakar, Sean Young Li, Cem Simsek, Saleh A. Alqahtani, Amy K. Kim, Ruhail Kohli, Ahmet Gurakar. Hepatocellular Carcinoma and the Role of Liver Transplantation: A Review. Journal of Clinical and Translational Hepatology 2021; 0(000): 000 doi: 10.14218/JCTH.2021.00125
|
28 |
|
29 |
Aurélie Beaufrère, Stefano Caruso, Julien Calderaro, Nicolas Poté, Jean-Charles Bijot, Gabielle Couchy, François Cauchy, Valérie Vilgrain, Jessica Zucman-Rossi, Valérie Paradis. Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies. Journal of Hepatology 2022; 76(2): 343 doi: 10.1016/j.jhep.2021.09.034
|
30 |
Dharmender Malik, Vineet Pant, Ishita Sen, Parul Thakral, Subha Shankar Das, Virupakshappa CB. The Role of PET-CT-Guided Metabolic Biopsies in Improving Yield of Inconclusive Anatomical Biopsies: A Review of 5 Years in a Teaching Hospital. Diagnostics 2023; 13(13): 2221 doi: 10.3390/diagnostics13132221
|
31 |
Akash Shukla, Shraddha Patkar, Sridhar Sundaram, Samir R. Shah, Meghraj Ingle, Amit Gupta, Amrit Gopan, Mrunal Kamat, Ravi Mohanka, Sandeep Singh, Swapnil Walke, Vikas Pandey, Mahesh Goel. Clinical Profile, Patterns of Care & adherence to Guidelines in Patients with Hepatocellular Carcinoma: Prospective multi-center Study. Journal of Clinical and Experimental Hepatology 2022; 12(6): 1463 doi: 10.1016/j.jceh.2022.05.006
|
32 |
Mona A. Omar, Mohamed M. Omran, Khaled Farid, Ashraf A. Tabll, Yasser E. Shahein, Tarek M. Emran, Ana Petrovic, Nikola R. Lucic, Robert Smolic, Tanja Kovac, Martina Smolic. Biomarkers for Hepatocellular Carcinoma: From Origin to Clinical Diagnosis. Biomedicines 2023; 11(7): 1852 doi: 10.3390/biomedicines11071852
|
33 |
Jianpeng Wang, Ping Xiao, Xishan Li, Wenyu Wu, Degang Shi, Wei Lin, Zuchang Wu. Predictive value of circulating immune cell changes in response to PD-1 blockade and TKI therapy in patients with hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2024; 48(7): 102390 doi: 10.1016/j.clinre.2024.102390
|
34 |
Gian Luca Grazi, Andrea Scarinci. Hepatocellular Carcinoma. Updates in Surgery 2023; : 199 doi: 10.1007/978-3-031-09371-5_24
|
35 |
A. Osman, S. Patel, M. Gonsalves, S. Renani, R. Morgan. Vascular Interventions in Oncology. Clinical Oncology 2024; 36(8): 473 doi: 10.1016/j.clon.2023.09.005
|
36 |
Antonio Gil-Gómez, Ángela Rojas, Chang-Hai Liu, Rocio Gallego-Duran, Rocio Muñoz-Hernandez, Giorgio Fassina, Patrizia Pontisso, Javier Ampuero, Manuel Romero-Gómez. Combination of squamous cell carcinoma antigen immunocomplex and alpha-fetoprotein in mid- and long-term prediction of hepatocellular carcinoma among cirrhotic patients. World Journal of Gastroenterology 2021; 27(48): 8343-8356 doi: 10.3748/wjg.v27.i48.8343
|
37 |
Kathleen Möller, Christoph F. Dietrich, Siegbert Faiss, Sven Mutze, Leonie Goelz. Alternativen histologischer Materialgewinnung – Wann und wie ist die histologische Sicherung mittels Ultraschall (US), Computertomografie (CT) oder Endosonografie (EUS) sinnvoll?. Zeitschrift für Gastroenterologie 2022; 60(06): 937 doi: 10.1055/a-1482-9448
|
38 |
Duan Xie, Dongxia Li, Fangrong Hu, Zhiyou Wang, Longhui Zhang, Mingzhu Jiang, Yuanli Wang. Terahertz Metamaterial Biosensor With Double Resonant Frequencies for Specific Detection of Early-Stage Hepatocellular Carcinoma. IEEE Sensors Journal 2023; 23(2): 1124 doi: 10.1109/JSEN.2022.3225344
|
39 |
Sobia Zaidi, Richard Amdur, Xiyan Xiang, Herbert Yu, Linda L. Wong, Shuyun Rao, Aiwu R. He, Karan Amin, Daewa Zaheer, Raj K. Narayan, Sanjaya K. Satapathy, Patricia S. Latham, Kirti Shetty, Chandan Guha, Nancy R. Gough, Lopa Mishra. Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer. Genes & Cancer 2022; 13: 9 doi: 10.18632/genesandcancer.220
|
40 |
Na Cheng, Yong Ren, Jing Zhou, Yiwang Zhang, Deyu Wang, Xiaofang Zhang, Bing Chen, Fang Liu, Jin Lv, Qinghua Cao, Sijin Chen, Hong Du, Dayang Hui, Zijin Weng, Qiong Liang, Bojin Su, Luying Tang, Lanqing Han, Jianning Chen, Chunkui Shao. Deep Learning-Based Classification of Hepatocellular Nodular Lesions on Whole-Slide Histopathologic Images. Gastroenterology 2022; 162(7): 1948 doi: 10.1053/j.gastro.2022.02.025
|
41 |
A. Shaaban, R. Salamah, Y. Abo Elseud, A. Mohanty, J. Albarrak. Liver Cancer in the Middle East. 2021; : 237 doi: 10.1007/978-3-030-78737-0_15
|
42 |
Aqib B. Chowdhury, Kosha J. Mehta. Liver biopsy for assessment of chronic liver diseases: a synopsis. Clinical and Experimental Medicine 2022; 23(2): 273 doi: 10.1007/s10238-022-00799-z
|
43 |
Chiharu Nakasu, Shinichiro Yamada, Hiroki Teraoku, Yu Saito, Tetsuya Ikemoto, Yuji Morine, Mitsuo Shimada. Agnogenic hepatic palisading granuloma: A case report. Kanzo 2023; 64(10): 504 doi: 10.2957/kanzo.64.504
|
44 |
Sara Fayazzadeh, Mahsa Ghorbaninejad, Amirhassan Rabbani, Javad Zahiri, Anna Meyfour. Predictive three-biomarker panel in peripheral blood mononuclear cells for detecting hepatocellular carcinoma. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-58158-9
|
45 |
Yao Wang, Dongbo Yuan, Hang Sun, Xiaoguang Pan, Fangnan Lu, Hong Li, Ying Huang, Shaoshan Tang. Non-invasive preoperative prediction of Edmondson-Steiner grade of hepatocellular carcinoma based on contrast-enhanced ultrasound using ensemble learning. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1116129
|
46 |
Xu Zhang, Chi Chen, Yan Wang, Jun Xu. Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation. Journal of Gastroenterology and Hepatology 2024; doi: 10.1111/jgh.16693
|
47 |
V. V. Breder, I. A. Pokataev, V. V. Petkau, M. Yu. Fedyanin, E. V. Ledin, V. E. Zagainov, S. V. Shapoval, D. A. Granov, P. V. Balakhnin, N. E. Kudashkin, I. V. Pogrebnyakov, N. V. Popova, E. A. Moroz. Advisory board resolution: The role of the adjuvant atezolizumab plus bevacizumab in patients with hepatocellular carcinoma at high risk of recurrence following surgical resection or ablation. Meditsinskiy sovet = Medical Council 2024; (22): 20 doi: 10.21518/ms2023-450
|
48 |
Gongzheng Wang, Feier Ding, Kaige Chen, Zhuoshuai Liang, Pengxi Han, Linxiang Wang, Fengyun Cui, Qiang Zhu, Zhaoping Cheng, Xingzhi Chen, Chencui Huang, Hongxia Cheng, Ximing Wang, Xinya Zhao. CT-based radiomics nomogram to predict proliferative hepatocellular carcinoma and explore the tumor microenvironment. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05393-3
|
49 |
Ang Hu, Zeming Hu, Jiankang Zhang, Bin Chen. Granulomatous inflammation mimicking primary hepatic carcinoma: A case report. Asian Journal of Surgery 2022; 45(9): 1736 doi: 10.1016/j.asjsur.2022.01.023
|
50 |
Theodoros Androutsakos, Konstantinos Dimitriadis, Konstantinos Revenas, Chrysovalantis Vergadis, Dimitrios-Dorotheos Papadakis, Stratigoula Sakellariou, Christos Vallilas, Gregorios Hatzis. Liver Biopsy: To Do or Not to Do – A Single-Center Study. Digestive Diseases 2023; 41(6): 913 doi: 10.1159/000533328
|
51 |
Sami Akbulut, Tevfik Tolga Sahin. Comment on experience with LDLT in patients with hepatocellular carcinoma and portal vein tumor thrombosis postdownstaging. International Journal of Surgery Case Reports 2020; 74: 36 doi: 10.1016/j.ijscr.2020.07.057
|
52 |
Nicola Personeni, Tiziana Pressiani, Lorenza Rimassa. Which choice of therapy when many are available? Current systemic therapies for advanced hepatocellular carcinoma. Health Science Reports 2020; 3(1) doi: 10.1002/hsr2.147
|
53 |
Jeongin Yoo, Dong Ho Lee. Usefulness of contrast-enhanced ultrasound-guided biopsy for suspected viable hepatocellular carcinoma after treatment: a single-arm prospective study. Ultrasonography 2024; 43(2): 88 doi: 10.14366/usg.23133
|
54 |
Anca Zgura, Mugur Cristian Grasu, Radu Lucian Dumitru, Letitia Toma, Laura Iliescu, Cosmin Baciu. An Investigative Analysis of Therapeutic Strategies in Hepatocellular Carcinoma: A Raetrospective Examination of 23 Biopsy-Confirmed Cases Emphasizing the Significance of Histopathological Insights. Cancers 2024; 16(10): 1916 doi: 10.3390/cancers16101916
|
55 |
Zhenya Gao, Huanxia Jia, Fang Yu, Hongfang Guo, Baoyu Li. KIF2C promotes the proliferation of hepatocellular carcinoma cells in vitro and in vivo. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10528
|
56 |
Cyril Dourthe, Céline Julien, Sylvaine Di Tommaso, Jean‐William Dupuy, Nathalie Dugot‐Senant, Alexandre Brochard, Brigitte Le Bail, Jean‐Frédéric Blanc, Laurence Chiche, Charles Balabaud, Paulette Bioulac‐Sage, Frédéric Saltel, Anne‐Aurélie Raymond. Proteomic Profiling of Hepatocellular Adenomas Paves the Way to Diagnostic and Prognostic Approaches. Hepatology 2021; 74(3): 1595 doi: 10.1002/hep.31826
|
57 |
Jiawei Shi, Junwei Liu, Xiaoxuan Tu, Bin Li, Zhou Tong, Tian Wang, Yi Zheng, Hongyu Shi, Xun Zeng, Wei Chen, Weiwei Yin, Weijia Fang. Single-cell immune signature for detecting early-stage HCC and early assessing anti-PD-1 immunotherapy efficacy. Journal for ImmunoTherapy of Cancer 2022; 10(1): e003133 doi: 10.1136/jitc-2021-003133
|
58 |
Xinxin Li, Weihua Cao, Ziyu Zhang, Shiyu Wang, Tingting Jiang, Wen Deng, Liu Yang, Xiaoyue Bi, Yanjie Lin, Yao Lu, Lu Zhang, Mengjiao Xu, Wei Yi, Yao Xie, Minghui Li. Nanoparticles and their application in the diagnosis of hepatocellular carcinoma. Nanotechnology Reviews 2024; 13(1) doi: 10.1515/ntrev-2024-0054
|
59 |
Xiaoyang Liu, Yang Guo, Lei Zhao, Joseph Misdraji, Tina Kapur, Thomas A. Abrams, Paul B. Shyn. Can MRI features predict clinically relevant hepatocellular carcinoma genetic subtypes?. Abdominal Radiology 2023; 48(6): 1955 doi: 10.1007/s00261-023-03876-3
|
60 |
Brandon M. Lehrich, Josephine Zhang, Satdarshan P. Monga, Renumathy Dhanasekaran. Battle of the biopsies: Role of tissue and liquid biopsy in hepatocellular carcinoma. Journal of Hepatology 2024; 80(3): 515 doi: 10.1016/j.jhep.2023.11.030
|
61 |
Gavin A. D. Metcalf. MicroRNAs: circulating biomarkers for the early detection of imperceptible cancers via biosensor and machine-learning advances. Oncogene 2024; 43(28): 2135 doi: 10.1038/s41388-024-03076-3
|
62 |
Damian J. Mole, Jonathan A. Fallowfield, Ahmed E. Sherif, Timothy Kendall, Scott Semple, Matt Kelly, Gerard Ridgway, John J. Connell, John McGonigle, Rajarshi Banerjee, J. Michael Brady, Xiaozhong Zheng, Michael Hughes, Lucile Neyton, Joanne McClintock, Garry Tucker, Hilary Nailon, Dilip Patel, Anthony Wackett, Michelle Steven, Fenella Welsh, Myrddin Rees, Leonidas G Koniaris. Quantitative magnetic resonance imaging predicts individual future liver performance after liver resection for cancer. PLOS ONE 2020; 15(12): e0238568 doi: 10.1371/journal.pone.0238568
|
63 |
Dongxia Li, Lizhen Zeng, Yuanli Wang, Hong-Wen Tang, Wen Xing Lee, Zhencheng Chen, Longhui Zhang, Yingchang Zou, Duan Xie, Fangrong Hu. Terahertz metamaterial biosensor for diagnosis of hepatocellular carcinoma at early stage. Applied Optics 2022; 61(16): 4817 doi: 10.1364/AO.459489
|
64 |
Jianhua Li, Li Zhang, Hao Xing, Yan Geng, Shaocheng Lv, Xiao Luo, Weiqiao He, Zhi Fu, Guangming Li, Bin Hu, Shengran Jiang, Zhe Yang, Ningqi Zhu, Quanbao Zhang, Jing Zhao, Yifeng Tao, Conghuan Shen, Ruidong Li, Feng Tang, Shusen Zheng, Yun Bao, Qiang He, Daoying Geng, Zhengxin Wang. The Absence of Intra‐Tumoral Tertiary Lymphoid Structures is Associated with a Worse Prognosis and mTOR Signaling Activation in Hepatocellular Carcinoma with Liver Transplantation: A Multicenter Retrospective Study. Advanced Science 2024; 11(21) doi: 10.1002/advs.202309348
|
65 |
Onyinye Ugonabo, Utibe-Abasi Sunday Udoh, Pradeep Kumar Rajan, Heather Reeves, Christina Arcand, Yuto Nakafuku, Tejas Joshi, Rob Finley, Sandrine V. Pierre, Juan Ramon Sanabria. The Current Status of the Liver Liquid Biopsy in MASH Related HCC: Overview and Future Directions. Biomolecules 2023; 13(9): 1369 doi: 10.3390/biom13091369
|
66 |
Abhiram Natu, Anjali Singh, Sanjay Gupta. Hepatocellular carcinoma: Understanding molecular mechanisms for defining potential clinical modalities. World Journal of Hepatology 2021; 13(11): 1568-1583 doi: 10.4254/wjh.v13.i11.1568
|
67 |
Mohamed Ismail , Sahiba Singh, Menna-Allah Elaskandrany , David s Kim, Yazan Abboud, Michael Bebawy, Abena Oduro, Ritik mahaveer Goyal, Omar Mohamed , Weizheng Wang. Fibrolamellar Hepatocellular Carcinoma (FLHCC) in a Young Patient Presenting With Nausea and Vomiting After a Greasy Meal. Cureus 2024; doi: 10.7759/cureus.55863
|
68 |
Di-guang Wen, Xiao-ping Zhao, Yu You, Zuo-jin Liu. Systematic analysis of immune-related genes based on a combination of multiple databases to build a diagnostic and a prognostic risk model for hepatocellular carcinoma. Cancer Immunology, Immunotherapy 2021; 70(3): 773 doi: 10.1007/s00262-020-02733-2
|
69 |
Nicole E. Rich, Amit G. Singal. Overdiagnosis of hepatocellular carcinoma: Prevented by guidelines?. Hepatology 2022; 75(3): 740 doi: 10.1002/hep.32284
|
70 |
Zhi Gao, Zhongshang Dai, Zhengxiao Ouyang, Dianqing Li, Sihuai Tang, Penglin Li, Xudong Liu, Yongfang Jiang, Deye Song. Radiomics analysis in differentiating osteosarcoma and chondrosarcoma based on T2-weighted imaging and contrast-enhanced T1-weighted imaging. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-78245-1
|
71 |
Yiting Liu, Ebuka-Olisaemeka Nwafor, Ziwei Li, Jilin Wang, Xiaojiao Feng, Huihui Li, Bei Jia, Hongfei Ma, Jiachen He, Jiaxin Pi, Zhidong Liu. Effects of Berberine on Liver Cancer. Natural Product Communications 2022; 17(5) doi: 10.1177/1934578X221102032
|
72 |
Zhao-Hui Zhang, Yi-Chao Zhuang, Wen-Xian Yang. Correlation of Fibroscan parameter with degree of liver fibrosis and liver function and its value for differential diagnosis of primary biliary cirrhosis and autoimmune hepatitis. World Chinese Journal of Digestology 2023; 31(11): 464 doi: 10.11569/wcjd.v31.i11.464
|
73 |
Xupeng Yang, Chen Yang, Shu Zhang, Haigang Geng, Andrew X. Zhu, René Bernards, Wenxin Qin, Jia Fan, Cun Wang, Qiang Gao. Precision treatment in advanced hepatocellular carcinoma. Cancer Cell 2024; 42(2): 180 doi: 10.1016/j.ccell.2024.01.007
|
74 |
Feier Ding, Min Huang, Ping Ren, Junlei Zhang, Zhengyu Lin, Yan Sun, Changhu Liang, Xinya Zhao. Quantitative information from gadobenate dimeglumine-enhanced MRI can predict proliferative subtype of solitary hepatocellular carcinoma: a multicenter retrospective study. European Radiology 2023; 34(4): 2445 doi: 10.1007/s00330-023-10227-9
|
75 |
Olivier Rouvière, Sébastien Crouzet. Prostate Cancer Diagnosis Without Histological Proof: Is Treating Images Reasonable?. European Urology Open Science 2022; 46: 1 doi: 10.1016/j.euros.2022.09.016
|
76 |
Odysseas P. Chatzipanagiotou, Constantinos Loukas, Michail Vailas, Nikolaos Machairas, Stylianos Kykalos, Georgios Charalampopoulos, Dimitrios Filippiadis, Evangellos Felekouras, Dimitrios Schizas. Artificial intelligence in hepatocellular carcinoma diagnosis: a comprehensive review of current literature. Journal of Gastroenterology and Hepatology 2024; 39(10): 1994 doi: 10.1111/jgh.16663
|
77 |
Vanessa F. Schmidt, Osman Öcal, Viktoria Walther, Matthias P. Fabritius, Olaf Dietrich, Philipp M. Kazmierczak, Lena Weiss, Sinan Deniz, Muzzafer R. Ümütlü, Daniel Puhr-Westerheide, Moritz Wildgruber, Jens Ricke, Max Seidensticker. Clinical benefits of MRI-guided freehand biopsy of small focal liver lesions in comparison to CT guidance. European Radiology 2024; 34(9): 5507 doi: 10.1007/s00330-024-10623-9
|
78 |
Xiaoming Wang, Jie Chen, Zhiqian Li, Yunkun Li, Yuxin Zhang, Qiyong Gong, Kui Luo. A branched polymer-based agent for efficient and precise targeting of fibrosis diseases by magnetic resonance imaging. Journal of Controlled Release 2024; 373: 905 doi: 10.1016/j.jconrel.2024.07.072
|
79 |
Charlotte Benoit, Aurélie Rodrigues, Julien Calderaro, Cécile Charpy, Sylvie Simonin, Jean-Charles Deybach, Laurent Gouya, Hervé Puy, Caroline Schmitt, René Farcy, Valérie Vilgrain, Valérie Paradis, Nicolas Pote, Fouad Lafdil, Sébastien Mule, Emmanuel Itti, Alain Luciani. Autofluorescence imaging within the liver: a promising tool for the detection and characterization of primary liver tumors. European Radiology 2022; 32(4): 2481 doi: 10.1007/s00330-021-08307-9
|
80 |
Jiabing Jiang, Jingyao Li, Zhiqiang Chu, Zhengzheng Tao, Wenjuan Cai, Jinxia Zhu, Robert Grimm, Qian Ji. In vivo multiparametric magnetic resonance imaging study for differentiating the severity of hepatic warm ischemia-reperfusion injury in a rabbit model. Magnetic Resonance Imaging 2020; 74: 105 doi: 10.1016/j.mri.2020.09.010
|
81 |
Chao-qun Li, Hui Huang, Si-min Ruan, Hang-tong Hu, Meng-fei Xian, Xiao-yan Xie, Ming-de Lu, Ming Kuang, Ying Wang, Li-da Chen. An assessment of liver lesions using a combination of CEUS LI-RADS and AFP. Abdominal Radiology 2022; 47(4): 1311 doi: 10.1007/s00261-022-03428-1
|
82 |
Omid Salehi, Eduardo A. Vega, Onur C. Kutlu, Keri Lunsford, Richard Freeman, Keren Ladin, Sylvia V. Alarcon, Vera Kazakova, Claudius Conrad. Poorly differentiated hepatocellular carcinoma: resection is equivalent to transplantation in patients with low liver fibrosis. HPB 2022; 24(7): 1100 doi: 10.1016/j.hpb.2021.12.001
|
83 |
Luca Ginanni Corradini, Tiziano Polidori, Luciano Maresca, Damiano Caruso, Andrea Laghi, Giovanni Simonetti, Matteo Stefanini. MRI-guided thoraco-abdominal percutaneous needle biopsy: our initial experience. European Radiology 2023; 33(8): 5719 doi: 10.1007/s00330-023-09763-1
|
84 |
Kailai Xiang, Baihui Jiang, Dong Shang. The overview of the deep learning integrated into the medical imaging of liver: a review. Hepatology International 2021; 15(4): 868 doi: 10.1007/s12072-021-10229-z
|
85 |
Duo Zuo, Jiawei Xiao, Haohua An, Yongzi Chen, Jianhua Li, Xiaohui Yang, Xia Wang, Li Ren. Screening for Lipid-Metabolism-Related Genes and Identifying the Diagnostic Potential of ANGPTL6 for HBV-Related Early-Stage Hepatocellular Carcinoma. Biomolecules 2022; 12(11): 1700 doi: 10.3390/biom12111700
|
86 |
Aurélie Beaufrère, Valérie Vilgrain, Valérie Paradis. Reply to: Correspondence regarding “Gene expression signature as a surrogate marker of microvascular invasion on routine hepatocellular carcinoma biopsies”. Journal of Hepatology 2022; 77(3): 894 doi: 10.1016/j.jhep.2022.06.011
|
87 |
Liyue Shen, Tao Peng, Jiahui Dong, Zhanwei Liang, Jihao Si, Hua Ye, Jie Xie, Xiaoping Yu, Xinhua Dai. Establishment of a multi-line immunochromatography based on magnetic nanoparticles for simultaneous screening of multiple biomarkers. Analytical and Bioanalytical Chemistry 2024; 416(22): 4823 doi: 10.1007/s00216-024-05432-4
|
88 |
Melissa Y. Lucero, Yuqi Tang, Chloe J. Zhang, Shengzhang Su, Joseph A. Forzano, Valeria Garcia, Xin Huang, David Moreno, Jefferson Chan. Activity-based photoacoustic probe for biopsy-free assessment of copper in murine models of Wilson’s disease and liver metastasis. Proceedings of the National Academy of Sciences 2021; 118(36) doi: 10.1073/pnas.2106943118
|
89 |
Omar Kamal, Natally Horvat, Sandeep Arora, Humaira Chaudhry, Mohab Elmohr, Lokesh Khanna, Pankaj Sharma Nepal, Manida Wungjramirun, Sadhna B. Nandwana, Anuradha S. Shenoy-Bhangle, James Lee, Ania Kielar, Robert Marks, Khaled Elsayes, Alice Fung. Understanding the role of radiologists in complex treatment decisions for patients with hepatocellular carcinoma. Abdominal Radiology 2023; 48(12): 3677 doi: 10.1007/s00261-023-04033-6
|
90 |
Franziska Hauth, Hannah J. Roberts, Theodore S. Hong, Dan G. Duda. Leveraging Blood-Based Diagnostics to Predict Tumor Biology and Extend the Application and Personalization of Radiotherapy in Liver Cancers. International Journal of Molecular Sciences 2022; 23(4): 1926 doi: 10.3390/ijms23041926
|
91 |
I. V. Pogrebnyakov. Standards for the Transarterial Chemoembolization Procedure as the Hepatocellular Carcinoma Treatment: Literature Review. Part 1. Journal of oncology: diagnostic radiology and radiotherapy 2024; 7(2): 63 doi: 10.37174/2587-7593-2024-7-2-63-75
|